Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
sulfamethoxazole, trimethoprim
Pharmaceutical Works POLPHARMA S.A. Medana Branch in Sieradz
J01EE01
sulfamethoxazole, trimethoprim
200mg/5ml+ 40mg/5ml
suspension oral
80ml glass bottle and measuring cup
Prescription
Registered
2022-08-10
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Biseptol Medana, 240 mg/5 ml, oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Trimethoprim (TM) and sulfamethoxazole (SMZ) 2.1 GENERAL DESCRIPTION Trimethoprim (TM) and sulfamethoxazole (SMZ). The combination of the two active substances TM and SMZ has established itself under the name co-trimoxazole. 2.2 QUALITATIVE AND QUANTITATIVE COMPOSITION 100 ml of suspension contains: sulfamethoxazole 4.0 g trimethoprim 0.8 g 5 ml of suspension contains 200 mg SMZ and 40 mg TM. _Excipients which shall be taken into account the medicinal product composition: _ 5 ml of suspension contains: 2.42 g of maltitol, 7.5 mg of methyl parahydroxybenzoate, 2.5 mg of propyl parahydroxybenzoate, 142,72 mg of propylene glycol, 14 mg of macrogolglycerol hydroxystearate, 38 mg of sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension. Suspension with white or light creamy color with a strawberry smell. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Owing to the sometimes-serious side effects of Biseptol Medana and the emergence of resistance, a risk- benefit assessment should always be made prior to using Biseptol Medana, compared to other active substances that may also be considered for these indications. Infections due to co-trimoxazole-sensitive organisms, such as: - Infections of the upper and lower respiratory tract and of the ear: acute exacerbations of chronic bronchitis, bronchiectasis, pneumonia (including _Pneumocystis jirovecii _ (formerly _carinii_ ) pneumonia), sinusitis, otitis media. - Urogenital infections: acute and chronic cystitis, pyelonephritis, urethritis, prostatitis. - Gastrointestinal infections including: travellers' diarrhoea, chronic typhoid fever carriers, cholera (as a complementary measure to fluid and electrolyte intake). Cotrimoxazole should only be used for the following infections if the following currently recommended antibiotics cannot be administered: - Typhoid fever, parat Read the complete document